TheProfitWatch

BIOA - BioAge Labs, Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
5.53 0.16 (2.89%) --- --- 0.04 (0.71%) --- 0.15 (2.71%) 0.0 (0.0%) 0.0 (0.0%)

Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of human aging. Its focus is metabolic disease, one of the greatest healthcare challenges. The pipeline Products of the company are NLRP3 inhibitors, APJ against, and others.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: AfterHours

Earnings & Ratios

Basic EPS:
-0.6
Diluted EPS:
-0.6
Basic P/E:
-9.4833
Diluted P/E:
-9.4833
RSI(14) 1m:
100.0
VWAP:
5.69
RVol:
0.4492

Events

Period Kind Movement Occurred At

Related News